Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Reshape Lifesciences Inc (NQ: RSLS )

5.080 +0.090 (+1.80%)
Streaming Delayed Price Updated: 11:50 AM EST, Dec 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Reshape Lifesciences Inc

< Previous 1 2 3 Next >
ReShape Reports Second Quarter 2021 Financial Results and Provides Business Update
Webinar to follow at 8:30 a.m. today SAN CLEMENTE, CA / ACCESSWIRE / August 16, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a leading developer and distributor of minimally invasive medical devices... 
From ReShape Lifesciences Inc.
Via AccessWire
ReShape Lifesciences Reports Preliminary Unaudited Second Quarter 2021 Financial Results and Provides Business Update
SAN CLEMENTE, CA / ACCESSWIRE / August 5, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ReShape Lifesciences(TM) CEO Bart Bandy Featured on the Big Biz Show
SAN CLEMENTE, CA / ACCESSWIRE / August 3, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced CEO Bart Bandy's featured interview on... 
From ReShape Lifesciences Inc.
Via AccessWire
ReShape Lifesciences to Report Second Quarter 2021 Financial and Operational Results on Thursday, August 5, 2021
Webinar will be available discussing recent major milestones that same day SAN CLEMENTE, CA / ACCESSWIRE / July 29, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss... 
From ReShape Lifesciences Inc.
Via AccessWire
ReShape Lifesciences(TM) Launches Online Consumer Marketplace Offering Products Supporting Four Key Dimensions of Wellness: Nutrition, Exercise, Sleep and Stress
SAN CLEMENTE, CA / ACCESSWIRE / July 13, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the launch of... 
From ReShape Lifesciences Inc.
Via AccessWire
ReShape Lifesciences Moves Lap-Band Manufacturing to United States
SAN CLEMENTE, CA / ACCESSWIRE / July 7, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced it has completed... 
From ReShape Lifesciences Inc.
Via AccessWire
ReShape Lifesciences Sees Lap-Band Growth as COVID-19 Pandemic Heightens Obesity Crisis
SAN CLEMENTE, CA / ACCESSWIRE / July 1, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight-loss solutions company, today announced that Lap-Band® utilization has increased... 
From ReShape Lifesciences Inc.
Via AccessWire
Exposures COVID-19
ReShape Lifesciences Completes $46 Million Capital Raise With Key Institutional Shareholders
Funding provides for the acceleration of its internal growth strategy and the continued development of Reshape's weight-loss portfolio SAN CLEMENTE, CA / ACCESSWIRE / June 30, 2021 / ReShape... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ReShape Lifesciences Enters into Warrant Exercise Transaction for $46.2 Million in Gross Proceeds
SAN CLEMENTE, CA / ACCESSWIRE / June 29, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a global weight-loss solutions leader, announced today that it has entered into a warrant exercise agreement... 
From ReShape Lifesciences Inc.
Via AccessWire
ReShape Lifesciences Closes First Day of Trading on the NASDAQ Capital Market
Shares of ReShape Lifesciences commenced trading on The Nasdaq Capital Market at market open on June 16, 2021 under the ticker symbol "RSLS" SAN CLEMENTE, CA / ACCESSWIRE / June 17, 2021 / ReShape... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ReShape Lifesciences Completes Merger with Obalon Therapeutics
Shares of ReShape Lifesciences to commence trading on The Nasdaq Capital Market on June 16, 2021 under ticker symbol "RSLS" Combination creates opportunity for ReShape to expand portfolio of FDA... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Product Safety Regulatory
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger
SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 15, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today the anticipated closing of their... 
From ReShape Lifesciences Inc.
Via AccessWire
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger
SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 8, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today that the parties anticipate the... 
From ReShape Lifesciences Inc.
Via AccessWire
Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
SAN DIEGO, CA / ACCESSWIRE / May 24, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
SAN DIEGO, CA / ACCESSWIRE / May 21, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021
Urging all Shareholders to Vote For Proposals Related to Merger with ReShape LifeSciences Inc. Meeting to be held via Webcast at 8:30 a.m. Pacific SAN DIEGO, CA / ACCESSWIRE / May 18, 2021 / Obalon... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ReShape Lifesciences Announces First Quarter 2021 Financial and Operational Results
SAN CLEMENTE, CA / ACCESSWIRE / May 17, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases,... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Fraud Intellectual Property
Exposures COVID-19 Intellectual Property Legal
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.